SG11202106839XA - Cellulose powder, use thereof, and tablets - Google Patents

Cellulose powder, use thereof, and tablets

Info

Publication number
SG11202106839XA
SG11202106839XA SG11202106839XA SG11202106839XA SG11202106839XA SG 11202106839X A SG11202106839X A SG 11202106839XA SG 11202106839X A SG11202106839X A SG 11202106839XA SG 11202106839X A SG11202106839X A SG 11202106839XA SG 11202106839X A SG11202106839X A SG 11202106839XA
Authority
SG
Singapore
Prior art keywords
tablets
cellulose powder
cellulose
powder
Prior art date
Application number
SG11202106839XA
Inventor
Tadahiro Kumagai
Kaede TAMARI
Naoya Yoshida
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Publication of SG11202106839XA publication Critical patent/SG11202106839XA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H8/00—Macromolecular compounds derived from lignocellulosic materials
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/12—Powdering or granulating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B1/00—Preparatory treatment of cellulose for making derivatives thereof, e.g. pre-treatment, pre-soaking, activation
    • C08B1/08—Alkali cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/08—Fractionation of cellulose, e.g. separation of cellulose crystallites
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C08L1/04—Oxycellulose; Hydrocellulose, e.g. microcrystalline cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/02—Cellulose; Modified cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2397/00—Characterised by the use of lignin-containing materials
    • C08J2397/02—Lignocellulosic material, e.g. wood, straw or bagasse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
SG11202106839XA 2018-12-27 2019-08-27 Cellulose powder, use thereof, and tablets SG11202106839XA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018245362 2018-12-27
JP2018245363 2018-12-27
PCT/JP2019/033506 WO2020136995A1 (en) 2018-12-27 2019-08-27 Cellulose powder, use thereof, and tablet

Publications (1)

Publication Number Publication Date
SG11202106839XA true SG11202106839XA (en) 2021-07-29

Family

ID=71125701

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202106839XA SG11202106839XA (en) 2018-12-27 2019-08-27 Cellulose powder, use thereof, and tablets

Country Status (9)

Country Link
US (1) US20220062182A1 (en)
EP (1) EP3904429A4 (en)
JP (2) JP6751491B1 (en)
CN (2) CN112585192B (en)
BR (1) BR112021011263A2 (en)
CA (1) CA3124534C (en)
SG (1) SG11202106839XA (en)
TW (1) TWI729476B (en)
WO (1) WO2020136995A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114455204B (en) * 2022-01-17 2023-09-29 黑龙江省绿色食品科学研究院 Preparation method of composite antihypertensive polypeptide edible packaging film
US20230372247A1 (en) * 2022-05-17 2023-11-23 Sigachi Industries Limited Self-disintegrating excipient composition for solid oral dosage forms
WO2024057828A1 (en) * 2022-09-15 2024-03-21 日本製紙株式会社 Method for grinding cellulose polymer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001335469A (en) 2000-05-26 2001-12-04 Lion Corp Method for producing solid preparation
JP5110757B2 (en) * 2000-07-05 2012-12-26 旭化成ケミカルズ株式会社 Cellulose powder
US20040043964A1 (en) * 2000-11-06 2004-03-04 Gomi Shun?Apos;Ichi Cellulosic particle for pharmaceuticals preparation
JP4151885B2 (en) 2002-07-12 2008-09-17 旭化成ケミカルズ株式会社 Water dispersible cellulose and method for producing the same
EP1873196B1 (en) 2005-04-22 2016-04-13 Asahi Kasei Chemicals Corporation Porous cellulose aggregate and molding composition thereof
IN2014DN10077A (en) * 2012-05-31 2015-08-21 Asahi Kasei Chemicals Corp
US10662258B2 (en) * 2012-05-31 2020-05-26 Asahi Kasei Chemicals Corporation Cellulose powder
US9592199B2 (en) * 2012-05-31 2017-03-14 Asahi Kasei Chemicals Corporation Cellulose powder
JP6138635B2 (en) * 2013-08-30 2017-05-31 旭化成株式会社 Cellulosic core particles and method for producing the same
US10016367B2 (en) * 2014-08-12 2018-07-10 Asahi Kasei Kabushiki Kaisha Cellulose micropowder
JP2019026558A (en) * 2017-07-25 2019-02-21 旭化成株式会社 tablet
JP2019112358A (en) * 2017-12-25 2019-07-11 旭化成株式会社 Cellulose including compact for suppressing separation segregation

Also Published As

Publication number Publication date
EP3904429A4 (en) 2022-02-23
CN117467166A (en) 2024-01-30
US20220062182A1 (en) 2022-03-03
CN112585192B (en) 2023-11-21
JP6751491B1 (en) 2020-09-02
EP3904429A1 (en) 2021-11-03
WO2020136995A1 (en) 2020-07-02
CA3124534A1 (en) 2020-07-02
BR112021011263A2 (en) 2021-08-31
JPWO2020136995A1 (en) 2021-02-18
CA3124534C (en) 2023-08-01
CN112585192A (en) 2021-03-30
TWI729476B (en) 2021-06-01
TW202027730A (en) 2020-08-01
JP2021004358A (en) 2021-01-14
JP7332549B2 (en) 2023-08-23

Similar Documents

Publication Publication Date Title
IL288816A (en) Aminobenzazepine compounds, immunoconjugates, and uses thereof
IL279015A (en) Anti-interleukin-17a antibody, pharmaceutical composition thereof and use thereof
IL272446A (en) Substituted penta- fused hexa-heterocyclic compounds, preparation method therefor, drug combination and use thereof
EP3582741C0 (en) Systems and methods for the fabrication of tablets, including pharmaceutical tablets
IL272638A (en) Quinoxaline derivatives, their preparation and pharmaceutical compositions containing them
PL3720418T3 (en) Nicotine tablet
IL273339A (en) Griseofulvin compound and pharmaceutical use thereof
HK1256674A1 (en) Deuterium-modified brigatinib derivatives, pharmaceutical compositions comprising same, and use thereof
EP3719050A4 (en) Compound and tablet
IL252897A0 (en) Indenyl compounds, pharmaceutical compositions, and medical uses thereof
SG11202106839XA (en) Cellulose powder, use thereof, and tablets
IL276753A (en) Afibrotic compounds, devices, and uses thereof
IL273573A (en) Nitrogen-containing heteroaryl compound, and pharmaceutical use thereof
PL3658122T3 (en) Pharmaceutical composition comprising sacubitril and valsartan
IL276323A (en) 4-methyldihydropyrimidinone compounds and pharmaceutical use thereof
SG11202101435XA (en) ANTIBODY AGAINST IL-1ß, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP3425043A4 (en) Regularly arranged spheroids having uniform size, and use thereof
GB2590189B (en) Lycorine derivative, and pharmaceutical composition and use thereof
ZA202004349B (en) Fluoralkenyl compounds, process for preparation and use thereof
PT3755685T (en) Aminomethyl-functionalized denatonium derivatives, their preparation and use
EP3694519A4 (en) The pharmaceutical combination comprising dapoxetine and phosphodiesterase type-5
EP3715344A4 (en) 1,4-benzodiazapin-2-one derivatives and use thereof
IL282999A (en) 1,3,4-oxadiazolone compound and pharmaceutical
IL274785A (en) Combination products containing dicycloplatin, preparation and use thereof
EP3777565A4 (en) Cellulose powder